Squamous Cell Carcinoma clinical trials
35 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study of ZEN003694 in People With Squamous Cell Lung Cancer
- Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients
- Toripalimab With Chemotherapy for Sinus Cancer
- Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
- A Study of JNJ-1761981 in Participants With Solid Tumors
- A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
- Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
- EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
- R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
- Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
- Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
- Raman Spectroscopy and Skin Cancer
- Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
- Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
- Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
- High-Resolution PET-CT Imaging for Surgical Margin Visualization
- Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
- Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Basal Cell Carcinoma Chemoprevention Trial
- Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
- Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery
- University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository
- Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
- The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Squamous Cell Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.